Do sitagliptin, insulin aspart, atorvastatin, bisoprolol, methylprednisolone, or sedazine (hydroxyzine) cause xerosis or dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Medication-Induced Xerosis and Dermatitis Assessment

Among the medications listed, sitagliptin and atorvastatin have documented associations with dermatitis, while methylprednisolone can paradoxically cause perioral dermatitis and skin atrophy with inadequate use; the remaining medications (insulin aspart, bisoprolol, and hydroxyzine/sedazine) are not established causes of xerosis or dermatitis, though hydroxyzine can worsen pre-existing contact dermatitis in ethylenediamine-sensitive patients.

Medications With Documented Dermatologic Adverse Effects

Sitagliptin (DPP-4 Inhibitor)

  • Established dermatologic reactions: Multiple case reports document sitagliptin-induced skin eruptions including fixed drug eruption, blaschkitis, and generalized skin eruptions with pruritus 1, 2, 3
  • Timing: Reactions can occur weeks to months after initiation (6 months reported in one case) 3
  • Clinical presentation: Erythematous plaques, vesicular eruptions, generalized rash with intense itching
  • Resolution: Typically resolves within 1-2 weeks after discontinuation, leaving post-inflammatory hyperpigmentation 1, 3

Atorvastatin (HMG-CoA Reductase Inhibitor)

  • Drug eruption documented: Case reports describe progressive rash developing after switching from other statins 4
  • Clinical pattern: Can present as localized eruption that progresses to involve multiple body areas
  • Important caveat: Cross-reactivity with other statins is possible; avoid retrial of alternative statins if drug eruption occurs 4

Methylprednisolone (Corticosteroid)

  • Paradoxical dermatologic effects: Topical steroids may cause perioral dermatitis and skin atrophy when used inadequately 5
  • Context-dependent: While systemic steroids treat inflammatory dermatoses, improper topical use can worsen skin conditions
  • Guideline recommendation: Should only be used under dermatologist supervision to avoid unwanted side effects 5

Medications NOT Associated With Xerosis/Dermatitis

Insulin Aspart

  • FDA-documented adverse effects: Erythema, local edema, and pruritus at injection sites (self-limiting) 6
  • Skin-related reactions: Lipodystrophy (lipoatrophy/lipohypertrophy), localized cutaneous amyloidosis at injection sites
  • Not xerosis or dermatitis: These are localized injection site reactions, not systemic xerosis or dermatitis

Bisoprolol (Beta-Blocker)

  • No documented association with xerosis or dermatitis in the provided evidence
  • May blunt recognition of hypoglycemia symptoms when used with insulin, but no direct dermatologic effects

Hydroxyzine/Sedazine (Antihistamine)

  • Paradoxical worsening: Can worsen contact dermatitis in patients with ethylenediamine sensitivity due to cross-reactivity 7
  • Therapeutic use: Actually used to treat pruritus in xerotic skin conditions 8
  • Not a cause: Does not cause xerosis or dermatitis de novo, but may exacerbate pre-existing contact dermatitis in sensitized individuals

Clinical Approach to Suspected Drug-Induced Dermatitis

When evaluating new-onset xerosis or dermatitis in patients on these medications:

  1. Temporal relationship: Document when medication was started relative to skin symptoms
  2. Morphology assessment: Characterize the rash pattern (localized vs. generalized, distribution, associated symptoms)
  3. Discontinuation trial: For sitagliptin or atorvastatin-associated eruptions, discontinue the offending agent
  4. Expected resolution: Monitor for improvement within 1-2 weeks after drug withdrawal
  5. Avoid cross-reactive agents: Do not retry other statins if atorvastatin caused eruption 4

Important pitfall: Do not attribute all skin changes to diabetes or age-related xerosis without considering medication timing and characteristics. Sitagliptin reactions can occur months after initiation, making temporal association less obvious 3.

References

3
Research

Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2012

Related Questions

How should I evaluate and manage a 22-year-old female with severe xerosis unresponsive to one month of petrolatum gel?
How should I manage a patient with an allergy to atorvastatin?
What is the most likely cause of a cutaneous vasculitis rash in an octogenarian patient on aspirin, atorvastatin, carvedilol, dapagliflozin (Farxiga), ezetimibe, pregabalin (Lyrica), rivaroxaban (Xarelto), and torsemide?
How to manage a patient with xerosis cutis (dry skin) who has body odor and avoids showering?
In a 67-year-old male with type 2 diabetes mellitus who developed rash and pruritus immediately after starting Jardiance (empagliflozin) 25 mg daily and Januvia (sitagliptin) 100 mg daily, what management steps should be taken?
What are the causes of a retractile testis?
Is ingestion of silica‑water (silicon dioxide mixed with water) hazardous to health?
Should a patient with hyperinflated lungs and a flattened diaphragm but no dyspnea receive bronchodilator or inhaled steroid therapy?
A patient’s chest X‑ray shows hyperinflated lungs with flattened diaphragms and pectus excavatum; they had a fever one week ago and a productive cough for two weeks. What is the appropriate diagnosis and management?
Can oral amoxicillin‑clavulanate (Augmentin) and oral clindamycin be used together to treat cellulitis?
What is the appropriate management of tachyarrhythmia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.